Abiprubart

· Kiniksa Pharmaceuticals International, plc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abiprubart, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease [Phase 2]